日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CT Body Composition Changes Predict Survival in Immunotherapy-Treated Cancer Patients: A Retrospective Cohort Study

CT扫描体成分变化可预测接受免疫疗法治疗的癌症患者的生存期:一项回顾性队列研究

Tamir, Shlomit; Behar, Hilla Vardi; Tal, Ronen; Jasper, Ruthy Tal; Armoni, Mor; Aloni, Hadar Pratt; Orad, Rotem Iris; Voet, Hillary; Atar, Eli; Grubstein, Ahuva; Stemmer, Salomon M; Markel, Gal

PD-1 inhibitor treatment outcomes for cutaneous squamous cell carcinoma in patients over 85: a comparative analysis

PD-1抑制剂治疗85岁以上皮肤鳞状细胞癌患者的疗效:一项比较分析

Amir, Ido; Edri, Nofar; Averbuch, Itamar; Asher, Nethanel; Markel, Gal; Ritter, Amit; Yaniv, Dan; Zavdy, Ofir; Bachar, Gideon; Cooper, Lisa; Kurman, Noga; Yosefof, Eyal

Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring

利用差异性删失数据重新分析尿路上皮癌化疗免疫疗法试验

Meirson, Tomer; Ofer, Jonathan; Zimhony-Nissim, Noa; Bareket-Samish, Avital; Markel, Gal; Neiman, Victoria; Cherny, Nathan; Goldstein, Daniel A; Gyawali, Bishal; Tannock, Ian; Rosenbaum, Eli

Clinical outcomes following PD-1 inhibitor elective discontinuation in cutaneous squamous cell carcinoma: exploring treatment de-escalation

皮肤鳞状细胞癌患者选择性停用PD-1抑制剂后的临床结果:探索治疗降阶方案

Averbuch, Itamar; Edri, Nofar; Asher, Nethanel; Markel, Gal; Hendler, Daniel; Ditzian Kugler, Hadas; Yosefof, Eyal; Kurman, Noga

TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction

TMED抑制剂可抑制细胞表面PD-1表达并克服T细胞功能障碍

Vredevoogd, David W; Apriamashvili, Georgi; Levy, Pierre L; Sinha, Sanju; Huinen, Zowi R; Visser, Nils L; de Bruijn, Beaunelle; Boshuizen, Julia; van Hal-van Veen, Susan E; Ligtenberg, Maarten A; Bleijerveld, Onno B; Lin, Chun-Pu; Díaz-Gómez, Judit; Sánchez, Santiago Duro; Markovits, Ettai; Simon Nieto, Juan; van Vliet, Alex; Krijgsman, Oscar; Markel, Gal; Besser, Michal J; Altelaar, Maarten; Ruppin, Eytan; Peeper, Daniel S

Assessing the effect of metastasis-directed therapy in oligometastatic disease using the restricted mean survival time

利用限制平均生存时间评估转移灶靶向治疗对寡转移性疾病的影响

Averbuch, Itamar; Moore, Assaf; Ludmir, Ethan B; Markel, Gal; Meirson, Tomer

Survival outcomes of population-wide colonoscopy screening: reanalysis of the NordICC data

人群结肠镜筛查的生存结果:对NordICC数据的重新分析

Meirson, Tomer; Markel, Gal; Goldstein, Daniel A

Peptriever: a Bi-Encoder approach for large-scale protein-peptide binding search

Peptriever:一种用于大规模蛋白质-肽结合搜索的双编码器方法

Gurvich, Roni; Markel, Gal; Tanoli, Ziaurrehman; Meirson, Tomer

Projecting complete redaction of clinical trial protocols (RAPTURE): redacted cross sectional study

临床试验方案完全删减计划(RAPTURE):删减后的横断面研究

Balaban, Nir; Mohyuddin, Ghulam Rehman; Kashi, Adi; Massarweh, Amir; Markel, Gal; Bomze, David; Goldstein, Daniel A; Meirson, Tomer

Gender Gap in Leadership of Clinical Trials

临床试验领导层中的性别差距

Waldhorn, Ithai; Bomze, David; Ben-Aharon, Irit; Schlosser, Shir; Markel, Gal; Ludmir, Ethan B; Meirson, Tomer